Yanjun Zhang

Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial

Yanjun Zhang, Gang Zeng, Hongxing Pan et al. · The Lancet Infectious Diseases · 2020 · 1.5K citations · Full text

Human infections with the emerging avian influenza A H7N9 virus from wet market poultry: clinical analysis and characterisation of viral genome

Yu Chen, Weifeng Liang, Shigui Yang et al. · The Lancet · 2013 · 838 citations · Full text

Viral Genome, Viral Evolution, Virus Epidemiology +9

Generation of a Broadly Useful Model for COVID-19 Pathogenesis, Vaccination, and Treatment

Jing Sun, Zhen Zhuang, Jian Zheng et al. · Cell · 2020 · 488 citations · Full text

Vaccination, Broadly Useful Model, Infectious Disease Modelling +11

Etiological and epidemiological features of acute respiratory infections in China

Zhongjie Li, Qing‐Bin Lu, Xiang Ren et al. · Nature Communications · 2021 · 468 citations · Full text

Asthma, Nationwide Prospective Surveillance, Respiratory Virus Immunity +16

Biological features of novel avian influenza A (H7N9) virus

Jianfang Zhou, Dayan Wang, Rongbao Gao et al. · Nature · 2013 · 361 citations · Full text

Viral Evolution, Biological Features, Virology +1